China's Jiangsu Suying Pharmaceutical Invests in API Plant, an Industrial Info Market Brief
China's Jiangsu Suying Pharmaceutical Invests in API Plant, an Industrial Info Market Brief
Attachment: api201909 jiangsu
China's Jiangsu Suying Pharmaceutical Company Limited is planning a $141 million investment package for a grassroot active pharmaceutical ingredient (API) plant in Jiangsu, China. The facility will produce as much as 1,439 tons per year of APIs, and the company will releases main equipment RFQs and subcontractor bid documents in the fourth quarter.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021